Both in Pharmaceuticals
Damora Therapeutics vs AnaptysBio
Over the past year DMRA returned −23.1% and ANAB returned −6.3%; their daily moves had a correlation of 0.10.
DMRA −23.1% ANAB −6.3%Growth of $1, one year, split-adjusted
| Metric | DMRA | ANAB |
|---|---|---|
| Price | $21.61 | $50.50 |
| Market cap | $1.33B | $1.51B |
| Today | −1.59% | +1.75% |
| 1 month | +4.6% | +0.3% |
| 6 months | — | −19.0% |
| Year to date | — | +4.2% |
| 1 year | — | +39.6% |
| Revenue growth (YoY) | — | −8.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −206.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | $540.5M | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 40.6% |
| Short % of float | 11.2% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).